Global Plasma Protein Therapeutics Competitive Landscape Professional Research Report 2025
Research Summary
Plasma protein therapeutics refers to a category of medical treatments derived from human plasma proteins, which are isolated and purified to produce therapeutic products. These proteins play essential roles in various physiological processes, and when deficient or dysfunctional, they can lead to medical conditions. Plasma protein therapeutics include a range of products such as clotting factors for hemophilia, immunoglobulins for immune disorders, albumin for maintaining blood volume, and other proteins involved in coagulation and immune response. These therapies are typically administered through intravenous infusion to patients with congenital or acquired disorders affecting the production or function of specific proteins. Plasma protein therapeutics have revolutionized the treatment of various rare diseases, providing life-saving and life-sustaining interventions for individuals with conditions that were once challenging to manage effectively. The production of these therapeutics involves the plasma fractionation process, where plasma is separated into its constituent parts, and specific proteins are isolated and purified for therapeutic use.
According to DIResearch's in-depth investigation and research, the global Plasma Protein Therapeutics market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Plasma Protein Therapeutics include Shire (Baxalta), CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Kamada etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Plasma Protein Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Plasma Protein Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Plasma Protein Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Plasma Protein Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Plasma Protein Therapeutics Include:
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
Plasma Protein Therapeutics Product Segment Include:
Coagulation Factor
Immune Globulin
Albumin
Others
Plasma Protein Therapeutics Product Application Include:
Hemophilia
Pelvic inflammatory disease (PID)
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Plasma Protein Therapeutics Industry PESTEL Analysis
Chapter 3: Global Plasma Protein Therapeutics Industry Porter’s Five Forces Analysis
Chapter 4: Global Plasma Protein Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Plasma Protein Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Plasma Protein Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Plasma Protein Therapeutics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Plasma Protein Therapeutics Product by Type
- 1.2.1 Coagulation Factor
- 1.2.2 Immune Globulin
- 1.2.3 Albumin
- 1.2.4 Others
- 1.3 Plasma Protein Therapeutics Product by Application
- 1.3.1 Hemophilia
- 1.3.2 Pelvic inflammatory disease (PID)
- 1.3.3 Others
- 1.4 Global Plasma Protein Therapeutics Market Size Analysis (2020-2032)
- 1.5 Plasma Protein Therapeutics Market Development Status and Trends
- 1.5.1 Plasma Protein Therapeutics Industry Development Status Analysis
- 1.5.2 Plasma Protein Therapeutics Industry Development Trends Analysis
- 2 Plasma Protein Therapeutics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Plasma Protein Therapeutics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Plasma Protein Therapeutics Market Analysis by Regions
- 4.1 Plasma Protein Therapeutics Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Plasma Protein Therapeutics Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Plasma Protein Therapeutics Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Plasma Protein Therapeutics Revenue Forecast by Region (2026-2032)
- 5 Global Plasma Protein Therapeutics Market Size by Type and Application
- 5.1 Global Plasma Protein Therapeutics Market Size by Type (2020-2032)
- 5.2 Global Plasma Protein Therapeutics Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Plasma Protein Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Plasma Protein Therapeutics Market Size by Type
- 6.4 North America Plasma Protein Therapeutics Market Size by Application
- 6.5 North America Plasma Protein Therapeutics Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Plasma Protein Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Plasma Protein Therapeutics Market Size by Type
- 7.4 Europe Plasma Protein Therapeutics Market Size by Application
- 7.5 Europe Plasma Protein Therapeutics Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Plasma Protein Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Plasma Protein Therapeutics Market Size by Type
- 8.4 China Plasma Protein Therapeutics Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Plasma Protein Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Plasma Protein Therapeutics Market Size by Type
- 9.4 APAC (excl. China) Plasma Protein Therapeutics Market Size by Application
- 9.5 APAC (excl. China) Plasma Protein Therapeutics Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Plasma Protein Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Plasma Protein Therapeutics Market Size by Type
- 10.4 Latin America Plasma Protein Therapeutics Market Size by Application
- 10.5 Latin America Plasma Protein Therapeutics Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Plasma Protein Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Plasma Protein Therapeutics Market Size by Type
- 11.4 Middle East & Africa Plasma Protein Therapeutics Market Size by Application
- 11.5 Middle East & Africa Plasma Protein Therapeutics Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Plasma Protein Therapeutics Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Plasma Protein Therapeutics Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Plasma Protein Therapeutics Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Shire (Baxalta)
- 13.1.1 Shire (Baxalta) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Shire (Baxalta) Plasma Protein Therapeutics Product Portfolio
- 13.1.3 Shire (Baxalta) Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 CSL
- 13.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 CSL Plasma Protein Therapeutics Product Portfolio
- 13.2.3 CSL Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Grifols
- 13.3.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Grifols Plasma Protein Therapeutics Product Portfolio
- 13.3.3 Grifols Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Octapharma
- 13.4.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Octapharma Plasma Protein Therapeutics Product Portfolio
- 13.4.3 Octapharma Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Kedrion
- 13.5.1 Kedrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Kedrion Plasma Protein Therapeutics Product Portfolio
- 13.5.3 Kedrion Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 LFB Group
- 13.6.1 LFB Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 LFB Group Plasma Protein Therapeutics Product Portfolio
- 13.6.3 LFB Group Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Biotest
- 13.7.1 Biotest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Biotest Plasma Protein Therapeutics Product Portfolio
- 13.7.3 Biotest Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 BPL
- 13.8.1 BPL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 BPL Plasma Protein Therapeutics Product Portfolio
- 13.8.3 BPL Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 RAAS
- 13.9.1 RAAS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 RAAS Plasma Protein Therapeutics Product Portfolio
- 13.9.3 RAAS Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 CBPO
- 13.10.1 CBPO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 CBPO Plasma Protein Therapeutics Product Portfolio
- 13.10.3 CBPO Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Hualan Bio
- 13.11.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Hualan Bio Plasma Protein Therapeutics Product Portfolio
- 13.11.3 Hualan Bio Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Kamada
- 13.12.1 Kamada Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Kamada Plasma Protein Therapeutics Product Portfolio
- 13.12.3 Kamada Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Plasma Protein Therapeutics Industry Chain Analysis
- 14.2 Plasma Protein Therapeutics Industry Raw Material and Suppliers Analysis
- 14.2.1 Plasma Protein Therapeutics Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Plasma Protein Therapeutics Typical Downstream Customers
- 14.4 Plasma Protein Therapeutics Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook